1 December 2022 false No description of principal activity Taxfiler 2024.5 11704644business:PrivateLimitedCompanyLtd2022-12-012023-11-30 117046442022-11-30 117046442022-12-012023-11-30 11704644business:AuditExempt-NoAccountantsReport2022-12-012023-11-30 11704644business:FilletedAccounts2022-12-012023-11-30 117046442023-11-30 11704644business:Director12022-12-012023-11-30 11704644business:RegisteredOffice2022-12-012023-11-30 117046442022-11-30 11704644core:WithinOneYear2023-11-30 11704644core:WithinOneYear2022-11-30 11704644core:ShareCapitalcore:PreviouslyStatedAmount2023-11-30 11704644core:ShareCapitalcore:PreviouslyStatedAmount2022-11-30 11704644core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-11-30 11704644core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-11-30 11704644core:PreviouslyStatedAmount2023-11-30 11704644core:PreviouslyStatedAmount2022-11-30 11704644business:SmallEntities2022-12-012023-11-30 11704644countries:EnglandWales2022-12-012023-11-30 11704644core:FurnitureFittings2022-12-012023-11-30 11704644core:FurnitureFittings2022-11-30 11704644core:FurnitureFittings2023-11-30 117046442021-12-012022-11-30 iso4217:GBP xbrli:pure
Company Registration No. 11704644 (England and Wales)
ISHAQ PHARMA LTD Unaudited accounts for the year ended 30 November 2023
ISHAQ PHARMA LTD Unaudited accounts Contents
Page
- 2 -
ISHAQ PHARMA LTD Company Information for the year ended 30 November 2023
Director
Shahbaz Ishaq
Company Number
11704644 (England and Wales)
Registered Office
17 HEATON PARK DRIVE BRADFORD BD9 5QH UNITED KINGDOM
Accountants
Axiom Accountants Ltd 42-44 Adelaide Street Bradford West Yorkshire BD5 0EA
- 3 -
ISHAQ PHARMA LTD Statement of financial position as at 30 November 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
810 
988 
Current assets
Debtors
3,611 
3,713 
Cash at bank and in hand
76,404 
62,945 
80,015 
66,658 
Creditors: amounts falling due within one year
(50,086)
(44,634)
Net current assets
29,929 
22,024 
Net assets
30,739 
23,012 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
30,738 
23,011 
Shareholders' funds
30,739 
23,012 
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 16 August 2024 and were signed on its behalf by
Shahbaz Ishaq Director Company Registration No. 11704644
- 4 -
ISHAQ PHARMA LTD Notes to the Accounts for the year ended 30 November 2023
1
Statutory information
ISHAQ PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 11704644. The registered office is 17 HEATON PARK DRIVE, BRADFORD, BD9 5QH, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
18% Reducing balance basis
4
Tangible fixed assets
Fixtures & fittings 
£ 
Cost or valuation
At cost 
At 1 December 2022
1,274 
At 30 November 2023
1,274 
Depreciation
At 1 December 2022
286 
Charge for the year
178 
At 30 November 2023
464 
Net book value
At 30 November 2023
810 
At 30 November 2022
988 
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Accrued income and prepayments
3,594 
3,713 
Other debtors
17 
- 
3,611 
3,713 
- 5 -
ISHAQ PHARMA LTD Notes to the Accounts for the year ended 30 November 2023
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Taxes and social security
4,435 
4,924 
Loans from directors
43,911 
38,860 
Accruals
1,740 
850 
50,086 
44,634 
7
Average number of employees
During the year the average number of employees was 2 (2022: 2).
- 6 -